Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Nuron obtains Wyeth assets from Pfizer

Executive Summary

Vaccines developer Nuron Biotech Inc. (focused primarily on CNS disorders and wound healing) has purchased assets associated with the HibTiter Haemophilus influenza Type b (Hib) conjugate vaccine from Pfizer Inc.’s absorbed Wyeth division. Nuron’s rights extend to the US, Japan, Korea, and various other markets.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing (Licensing)
    • Product Purchase
    • Reverse Licensing

Related Companies